Stem Cell-Based Treatment Collaboration for Corneal Vision Impairment, International Stem Cell Corporation (OTCBB: ISCO)
July 7th, 2010
No comments
ISCO.OB and Sankara Nethralaya commenced a collaboration to develop (ISCO’s) CytoCor™ stem cell derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. Read more…
